ViroPharma stock surges on Vancocin price hike

ViroPharma's stock surged yesterday after the company announced its third double-digit price hike on Vancocin since it acquired the antibiotic last December. A 20-unit package of Vancocin will now cost $242.10, up from $195.76. Wall Street loves higher prices for drugs and bid up ViroPharma stock by more than 30 percent. ViroPharma paid Eli Lilly $116 million plus royalties for the drug.

- read this AP report for more

Suggested Articles

Rachel Humphrey, M.D., who joined CytomX as chief medical officer after heading immuno-oncology at AstraZeneca and Eli Lilly, has made her exit.

Scientists have discovered a scorpion toxin could inspire treatments to block the inflammation that triggers chronic pain.

The phase 2 success keeps Hal Barron’s group on track to file for approval in multiple myeloma by the end of the year.